{"id":245575,"date":"2026-09-15T10:07:43","date_gmt":"2026-09-15T04:37:43","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=245575"},"modified":"2026-09-15T10:07:43","modified_gmt":"2026-09-15T04:37:43","slug":"why-morepen-laboratories-share-price-fall-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-morepen-laboratories-share-price-fall-today-2026\/","title":{"rendered":"Morepen Laboratories (MOREPENLAB) Share Price Falls 6.25% Today; Valuation and Sector Context in Focus"},"content":{"rendered":"
Morepen Laboratories (MOREPENLAB)<\/a>share price fell to Rs 108.7 today, down 6.25% from the previous close. Market cap was Rs 6,353.52 crore.<\/em><\/div>\n

Morepen Laboratories Share Price fell to Rs 108.70 on 15 September 2026, down Rs 7.25 or 6.25% from the previous close of Rs 115.95. The move took the company\u2019s market capitalisation to Rs 6,353.52 crore. The stock belongs to the Mid Cap category in the Healthcare sector\u2019s Pharmaceuticals & Drugs industry.<\/p>\n

The supplied data confirms the decline, but it does not identify a company-specific catalyst behind it. That makes the available numbers the main basis for analysis. The stock opened at Rs 116.15, touched a high of Rs 116.75, slipped to a low of Rs 104.40, and was trading at Rs 108.70 at the captured time. Turnover stood at Rs 10.05 crore.<\/p>\n

For readers tracking today\u2019s move, the main questions are straightforward: how the intraday weakness developed, whether valuation remains demanding relative to industry benchmarks, and how Morepen\u2019s profitability compares with larger pharmaceutical peers. Those three pieces together explain why the stock is drawing attention despite the absence of a stated trigger in the supplied dataset.<\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n